Bronchospasm mechanisms in experimental microbial sensitization. II. Pathochemical stage.

Area of Science:

• Immunology
• Pathology
• Pharmacology

Background:

• Bronchospasm is a significant respiratory condition with complex underlying mechanisms.
• Understanding the specific mediators involved in different types of allergic reactions is crucial for effective treatment.

Purpose of the Study:

• To elucidate the pathochemical mechanisms of bronchospasm in experimental allergies.
• To differentiate the roles of various mediators in Type I, III, and IV hypersensitivity reactions.

Main Methods:

• Induction of experimental allergies in guinea pigs using microbial antigens.
• Analysis of bronchospasm mediators, including histamine, SRS-A, acetylcholine, and lymphokines.
• Pharmacological interventions, such as atropine, to block specific responses.

Main Results:

• Type I allergies showed bronchospasm mediated by histamine and SRS-A.
• Type III allergies (immune complexes) triggered mast cell degranulation and histamine release via complement activation.
• Type IV hypersensitivity (lymphokine-mediated bronchospasm) occurred independently of histamine and mast cells, but was blocked by atropine.
• Spasmogenic lymphokines were identified as large, thermolabile molecules.

Conclusions:

• Bronchospasm mechanisms vary significantly across different hypersensitivity types.
• Histamine and SRS-A are key in Type I, while complement and mast cells mediate Type III responses.
• Type IV hypersensitivity involves a distinct pathway mediated by atropine-sensitive lymphokines, highlighting different therapeutic targets.